Oncology & Cancer
Researchers take early step toward leukemia drug therapy
A McMaster stem cell research team has made an important early step in developing a new class of therapeutics for patients with a deadly blood cancer.
Feb 16, 2021
0
10
News tagged with aml patients
Oncology & Cancer
Global trial reveals life saving drug for acute myeloid leukemia
A landmark paper published today in the New England Journal of Medicine describes the results from a global trial across 148 sites in 23 countries, showing a 30 percent improvement in survival in patients with acute myeloid ...
Dec 23, 2020
0
113
Oncology & Cancer
Why do Black patients fare worse with blood cancer than whites?
(HealthDay)—A pair of studies shed new light on why a relatively rare blood cancer—acute myeloid leukemia (AML)—is more deadly among Black patients.
Dec 11, 2020
1
2
Oncology & Cancer
Patient race linked to poorer survival in acute myeloid leukemia
Self-reported patient race is the most important factor associated with poorer survival in patients with acute myeloid leukemia (AML), according to a study presented at the annual meeting of the American Society of Hematology, ...
Dec 9, 2020
0
1
Oncology & Cancer
Superior outcomes for acute myeloid leukemia patients in clinical trial
Patients participating in The Leukemia & Lymphoma Society's (LLS) groundbreaking precision medicine Beat AML Master Clinical Trial had superior outcomes compared to acute myeloid leukemia (AML) patients who opted for standard ...
Oct 27, 2020
0
33
Oncology & Cancer
Combination therapy improves survival outcomes for patients with acute myeloid leukemia
A combination regimen of venetoclax and azacitidine was safe and improved overall survival (OS) over azacitidine alone in certain patients with acute myeloid leukemia (AML), according to the Phase III VIALE-A trial led by ...
Aug 13, 2020
0
5
Oncology & Cancer
Research team illuminates potential new treatment in acute myeloid leukemia
Tyrosine kinases are protein enzymes that have many functions within cells, including cell signaling, growth, and division. Sometimes these enzymes can be overactive, which helps cancer cells survive and multiply. A tyrosine ...
Jul 31, 2020
0
72
Oncology & Cancer
Combination therapy well-tolerated and highly effective for patients with IDH1-mutated AML
A combination therapy of ivosenidib (IVO) plus venetoclax (VEN) with or without azacitidine (AZA) was found to be effective against a specific genetic subtype of acute myeloid leukemia (AML) in a Phase Ib/II trial led by ...
May 28, 2020
0
8
Oncology & Cancer
Drug prevents severe cardiac events in children undergoing chemotherapy for AML
The cardioprotective drug dexrazoxane preserved cardiac function in pediatric patients undergoing chemotherapy for acute myeloid leukemia (AML) without compromising overall patient survival and potentially improving it, according ...
Apr 28, 2020
0
0
Oncology & Cancer
Cheap drug may alleviate treatment-resistance in leukemia
A common and inexpensive drug may be used to counteract treatment resistance in patients with acute myeloid leukemia (AML), one of the most common forms of blood cancer. This is the conclusion of a study in mice and human ...
Jan 17, 2020
1
5
